Patents by Inventor Catherine Ott

Catherine Ott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR ISOLATING EXOSOMES
    Publication number: 20160370265
    Abstract: The invention concerns a method for isolating exosomes from a biological liquid, comprising at least the following two successive steps of affinity purification: a) a first step using at least one specific anti-ligand of a generic ligand of the exosomes, so as to obtain a population P of exosomes, said exosomes being separated from said anti-ligand, and b) a second step, applied on the population P of exosomes, using at least one specific anti-ligand of a ligand characteristic of a subpopulation SP of exosomes, so as to obtain said subpopulation SP of exosomes, said exosomes being separated or not from said anti-ligand. as well as the applications of such method.
    Type: Application
    Filed: December 3, 2014
    Publication date: December 22, 2016
    Inventors: Catherine OTT, François MALLET, Laurence GENERENAZ
  • METHOD FOR DETECTINGAND/OR ASSAYING ANNEXIN A3 FROMA MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF
    Publication number: 20160291028
    Abstract: Method and pack for detecting and/or assaying annexin A3 from a mammal in blood or at least one derivative thereof.
    Type: Application
    Filed: June 5, 2013
    Publication date: October 6, 2016
    Applicant: bioMerieux
    Inventors: Yasemin ATAMAN-ONAL, Genevieve CHOQUET-KASTYLEVSKY, Hader HAIDOUS, Sandrine MICHEL-BUSSERET, Catherine OTT
  • METHOD FOR DETECTING AND/OR ASSAYING ANNEXIN A3 FROM A MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF
    Publication number: 20150177251
    Abstract: Method and pack for detecting and/or assaying annexin A3 from a mammal in blood or at least one derivative thereof.
    Type: Application
    Filed: June 5, 2013
    Publication date: June 25, 2015
    Applicant: bioMérieux
    Inventors: Yasemin Ataman-Öal, Geneviève Choquet-Kastylevsky, Hader Haidous, Sandrine Michel-Busseret, Catherine Ott
  • Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region
    Patent number: 8088910
    Abstract: An isolated polynucleotide having a nucleotide sequence selected from the group consisting of (a) SEQ ID NO: 21, (b) the full-length sequences encoding a polypeptide having a peptide sequence selected from the group consisting of SEQ ID NOs: 25 and 26, and (c) the full-length complementary sequences to the sequences set forth in (a) or (b).
    Type: Grant
    Filed: May 10, 2010
    Date of Patent: January 3, 2012
    Assignee: Biomerieux
    Inventors: Glaucia Paranhos-Baccala, Florence Komurian-Pradel, Frederic Bedin, Mireille Sodoyer, Catherine Ott, Francois Mallet, Herve Perron, Bernard Mandrand
  • RETROVIRAL NUCLEIC MATERIAL AND NUCLEOTIDE FRAGMENTS, IN PARTICULAR ASSOCIATED WITH MULTIPLE SCLEROSIS AND/OR RHEUMATOID ARTHRITIS, FOR DIAGNOSTIC, PROPHYLACTIC AND THERAPEUTIC USES
    Publication number: 20100285448
    Abstract: An isolated polynucleotide having a nucleotide sequence selected from the group consisting of (a) SEQ ID NO: 21, (b) the full-length sequences encoding a polypeptide having a peptide sequence selected from the group consisting of SEQ ID NOs: 25 and 26, and (c) the full-length complementary sequences to the sequences set forth in (a) or (b).
    Type: Application
    Filed: May 10, 2010
    Publication date: November 11, 2010
    Applicant: BIOMERIEUX
    Inventors: Glaucia PARANHOS-BACCALA, Florence Komurian-Pradel, Frederic Bedin, Mireille Sodoyer, Catherine Ott, Francois Mallet, Herve Perron, Bernard Mandrand
  • Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region
    Patent number: 7771927
    Abstract: The invention concerns a nucleic material, in isolated or purified state, and a nucleotide fragment comprising a nucleotide sequence selected from the group consisting in (i) the sequences SEQ ID NO: 112, SEQ ID NO:114, SEQ ID NO: 117, SEQ ID NO: 120, SEQ ID NO. 124, SEQ ID NO: 130, SEQ ID NO: 141 and SEQ ID NO: 142, (ii) the complementary sequences of sequences (i); and (iii) the sequences equivalent to sequences (ii) and (iii), in particular the sequence having for every series of 100 contiguous monomers, at least 50%, preferably 70% homology with sequences (i) and (ii) respectively. The invention also concerns their uses for detecting a retrovirus associated with multiple sclerosis and/or rheumatoid arthritis.
    Type: Grant
    Filed: July 7, 1998
    Date of Patent: August 10, 2010
    Assignee: Biomerieux
    Inventors: Glaucia Paranhos-Baccala, Florence Komurian-Pradel, Frederic Bedin, Mireille Sodoyer, Catherine Ott, Francois Mallet, Herve Perron, Bernard Mandrand